# Clinical Outcome Study for Dysferlinopathy

> **NCT01676077** · — · UNKNOWN · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 200 (estimated)

## Conditions studied

- Dysferlinopathy
- LGMD2B Now Classified as LGMDR2
- Miyoshi Myopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01676077
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676077, "Clinical Outcome Study for Dysferlinopathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01676077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*